Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Financial Results:
Jubilant Ingrevia Ltd reported Revenues for Q2FY25 of ₹1,045.00 Crores up from ₹1,020.00 Crore year on year, a rise of 2.45%.
Total Expenses for Q2FY25 of ₹976.00 Crores up from ₹949.00 Crores year on year, a rise of 2.85%.
Consolidated Net Profit of ₹59.00 Crores up 3.51% from ₹57.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹3.70, up 2.49% from ₹3.61 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.